๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Etizolam in the treatment of generalized anxiety disorder: a double-blind study versus placebo

โœ Scribed by Casacchia, Massimo; Bolino, Francesca; Ecari, Ugo

Book ID
126297898
Publisher
Informa plc
Year
1990
Tongue
English
Weight
552 KB
Volume
12
Category
Article
ISSN
0300-7995

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Escitalopram in the treatment of general
Escitalopram in the treatment of generalized anxiety disorder: Double-blind, placebo controlled, flexible-dose study
โœ Jonathan R.T. Davidson; Anjana Bose; Andrew Korotzer; Hongjie Zheng ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 128 KB ๐Ÿ‘ 2 views

Escitalopram has been shown in clinical trials to improve anxiety symptoms associated with depression, panic disorder, and social anxiety disorder. This study was designed to evaluate the efficacy and tolerability of escitalopram in the treatment of generalized anxiety disorder (GAD). Outpatients (1

Alprazolam in the treatment of generaliz
Alprazolam in the treatment of generalized anxiety and panic disorders: A double-blind placebo-controlled study
โœ G. Chouinard; L. Annable; R. Fontaine; L. Solyom ๐Ÿ“‚ Article ๐Ÿ“… 1982 ๐Ÿ› Springer ๐ŸŒ English โš– 472 KB

In a double-blind controlled study lasting 8 weeks, 50 anxious psychoneurotic outpatients with a primary diagnosis of generalized anxiety or panic disorder were randomly assigned to alprazolam (n = 30), a new benzodiazepine, or placebo (n = 20), after a washout period of 1 week. Alprazolam at dosage